Vesugen (20 mg Vial) Dosage Protocol
Reconstitution and dosing guide for the 20 mg Vesugen vial — a short-peptide bioregulator (Lys-Glu-Asp, 'KED') from the Khavinson family, studied for vascular-system support.
Quickstart Highlights
Vesugen is a synthetic tripeptide bioregulator (Lys-Glu-Asp, or 'KED') from the Khavinson family of short 'peptide bioregulators.' It is studied for the vascular system — research suggests these peptides help normalize tissue-specific gene expression and support endothelial and vascular function. Bioregulators are used in short, low-dose courses; human evidence comes largely from Russian research.
- Composition: 20 mg Vesugen (Lys-Glu-Asp / KED) per vial
- Reconstitute: Add 2.0 mL bacteriostatic water → 10 mg/mL concentration
- Easy measuring: At 10 mg/mL, 1 unit (0.01 mL) on a U-100 syringe = 100 mcg (so 2 mg = 20 units)
- Storage: Lyophilized: −20 °C (−4 °F); reconstituted: 2–8 °C (35.6–46.4 °F), protected from light, use within 2–4 weeks
Dosing & Reconstitution Guide
Subcutaneous protocol — typically a short course of 10–20 days
Subcutaneous Protocol (20 mg vial, 2 mL = 10 mg/mL)
| Protocol | Daily Dose | Units (U-100) | Course |
|---|---|---|---|
| Standard | 2 mg once daily | 20 units (0.20 mL) | 10–20 days |
Administration: Inject once daily subcutaneously during a short course (commonly 10–20 days), then pause. Bioregulator doses are low and course-based rather than continuous. A 20 mg vial covers roughly one 10-day course at 2 mg/day.
Reconstitution Steps
- Allow the vial to reach room temperature (15–20 minutes out of cold storage).
- Draw 2.0 mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall to avoid foaming.
- Gently swirl or roll until fully dissolved (do not shake).
- Label with date and concentration; refrigerate at 2–8 °C, protected from light.
Result: 10 mg/mL concentration
How This Works
Khavinson short-peptide bioregulators such as Vesugen (KED) are proposed to act as signaling fragments that bind regions of DNA and influence tissue-specific gene expression — in Vesugen's case, peptides associated with the vascular wall and endothelium.
Research in this family describes geroprotective and tissue-normalizing effects; rigorous large-scale human trials remain limited, so results should be interpreted cautiously.
Key Administration Notes
- Bioregulators are typically used in short courses (often 10–20 days), not continuously.
- Doses are low; human data come largely from Russian research literature.
- Use new sterile insulin syringes; rotate sites; sharps disposal.
- Document dose, course length, and dates for consistency.
References
Khavinson VK, et al. Short peptide bioregulators and the vascular peptide KED (Vesugen). View Source
Khavinson VK. Peptide regulation of gene expression and aging. View Source
⚠️ Research & Educational Purposes Only
This information is provided for research and educational purposes only. The compounds discussed are intended for laboratory research use only and are not approved for human consumption. Always consult qualified healthcare professionals for medical advice. Individual results may vary. This is not medical advice.